Perioperative Management and Outcomes after Endovascular Mechanical Thrombectomy in Patients with Submassive (Intermediate-Risk) Pulmonary Embolism: A Retrospective Observational Cohort Study.

acute submassive pulmonary embolism catheter-directed intervention endovascular therapy intermediate-risk pulmonary embolism interventional radiology mechanical thrombectomy

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
27 Aug 2024
Historique:
received: 10 07 2024
revised: 17 08 2024
accepted: 26 08 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 14 9 2024
Statut: epublish

Résumé

Pulmonary embolism (PE) embodies a large healthcare burden globally and is the third leading cause of morbidity and mortality worldwide. Submassive (intermediate-risk) PE accounts for 40% of this burden. However, the optimal treatment pathway for this population remains complex and ill-defined. Catheter-directed interventions (CDIs) have shown promise in directly impacting morbidity and mortality while demonstrating a favorable success rate, safety profile, and decreased length of stay (LOS) in the intensive care unit and hospital. This retrospective review included 22 patients (50% female) with submassive PE who underwent mechanical thrombectomy (MT). A total of 45% had a contraindication to thrombolytics, the mean pulmonary embolism severity index was 127, 36% had saddle PE, the average decrease in mean pulmonary artery pressure (PAP) was 7.2 mmHg following MT, the average LOS was 6.9 days, the 30-day mortality rate was 9%, the major adverse event (MAE) rate was 9%, and the readmission rate was 13.6%. A total of 82% had successful removal of thrombus during MT with no major bleeding complications, intracranial hemorrhage events, or device-related deaths. Acknowledging the limitation of our small sample size, our data indicate that MT in the intermediate-high-risk submassive pulmonary embolism (PE) cohort resulted in a decreased hospital length of stay (LOS) and in-hospital mortality compared to standard anticoagulation therapy alone.

Identifiants

pubmed: 39273738
pii: healthcare12171714
doi: 10.3390/healthcare12171714
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Michael P Merren (MP)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN 55902, USA.

Mitchell R Padkins (MR)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55902, USA.

Hector R Cajigas (HR)

Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55902, USA.

Newton B Neidert (NB)

Department of Radiology, Mayo Clinic, Rochester, MN 55902, USA.

Arnoley S Abcejo (AS)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN 55902, USA.

Omar Elmadhoun (O)

Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN 55902, USA.

Classifications MeSH